Livrables Websites, patent fillings, videos etc. (8) CoroNAb website for dissemination of results, and for fostering broader protocol, reagent, and result sharing by the scientific community CoroNAb website for dissemination of results, and for fostering broader protocol, reagent, and result sharing by the scientific community. Formulation characteristics and physicochemical evaluation of antigen-adjuvant combinations Formulation characteristics and physicochemical evaluation of antigen-adjuvant combinations. Shared plasmid design We will share out plasmid designs, right from the start of the project. Initially, this will be through our collaboration network, and subsequently this will be on the CoroNAb website. Predicted antigen-specific antibody variants. Predicted antigenspecific antibody variants 1 month after receiving NGS data fromimmunized animal Shared 2019-nCoV spike binding results for mAbs Shared 2019-nCoV spike binding results for mAbs. Shared nanobody sequences of confirmed binders, and data from NGS library sequencing Shared nanobody sequences of confirmed binders, and data from NGS library sequencing. Shared 2019-nCoV spike binding results for nanobodies Shared 2019-nCoV spike binding results for nanobodies. Shared mAb sequences, including NGS data D3.1 Shared mAb sequences, including NGS data. Open Research Data Pilot (5) Safety and immunogenicity data for each subunit /adjuvant combination. Selection of the best nCoV spike protein and adjuvant combination for immunizations of larger animals Safety and immunogenicity data for each subunit/adjuvant combination. Selection of the best nCoV spike protein and adjuvant combination for immunizations of larger animals. Scenarios will be developed for rollout of new antiviral therapy and a range of impacts will be examined in terms of impact on mortality and hospital bed usage Models of interventions and new forecasts will be published online. Update of DMP The draft management plan will be updated. Neutralization results for isolated monoclonal antibodies and camelid nanobodies, as well as modified mAbs D4.2. Neutralization results for isolated monoclonal antibodies and camelid nanobodies (aims 2 Deliver an ongoing series of progressively optimized anti-nCoV mAbs to KI for neutralization screening. Deliver an ongoing series of progressively optimized antinCoV mAbs to KI for neutralization screening Other (1) Mathematical model will be released as open source R package. Model projections will be published online. Mathematical model will be released as open source R package. Model projections will be published online. Demonstrators, pilots, prototypes (2) 2019-nCoV neutralization assay SOP, and dissemination of relevant plasmids. 2019-nCoV neutralization assay SOP, and dissemination of relevant plasmids. Deliver lead candidate anti-nCoV mAbs (from hybridoma combinatorial library screens) to KI for neutralization screening Deliver lead candidate antinCoV mAbs from hybridoma combinatorial library screens to KI for neutralization screening Documents, reports (2) Virus evolution: The impact of antiviral therapies on evolution of the virus will be explored in terms of plausible impacts on virulence and development of resistance At least one study will be published which examines the impact of widespread antiviral therapy on evolution of drug resistance and virulence of 2019nCoV Shared expression results Shared expression results, yields, and working protocols for all constructs. This will be ongoing throughout the project. Publications Peer reviewed articles (24) Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies Auteurs: Pradeepa Pushparaj, Andrea Nicoletto, Daniel J. Sheward, Hrishikesh Das, Xaquin Castro Dopico, Laura Perez Vidakovics, Leo Hanke, Mark Chernyshev, Sanjana Narang, Sungyong Kim, Julian Fischbach, Simon Ekström, Gerald McInerney, B. Martin Hällberg, Ben Murrell. Martin Corcoran, Gunilla B. Karlsson Hedestam Publié dans: Immunity, 2022, ISSN 1097-4180 Éditeur: Cell Press DOI: 10.1016/j.immuni.2022.12.005 Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England Auteurs: Erik Volz, Swapnil Mishra, Meera Chand, Jeffrey C. Barrett, Robert Johnson, Lily Geidelberg, Wes R. Hinsley, Daniel J. Laydon, Gavin Dabrera, Áine O’Toole, Robert Amato, Manon Ragonnet-Cronin, Ian Harrison, Ben Jackson, Cristina V. Ariani, Olivia Boyd, Nicholas J. Loman, John T. McCrone, Sónia Gonçalves, David Jorgensen, Richard Myers, Verity Hill, David K. Jackson, Katy Gaythorpe, Natalie Gr Publié dans: Nature, Issue 593/7858, 2021, Page(s) 266-269, ISSN 0028-0836 Éditeur: Nature Publishing Group DOI: 10.1038/s41586-021-03470-x DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice Auteurs: Inga Szurgot, Leo Hanke, Daniel J. Sheward, Laura Perez Vidakovics, Ben Murrell, Gerald M. McInerney, Peter Liljeström Publié dans: Scientific Reports, Issue 11/1, 2021, ISSN 2045-2322 Éditeur: Nature Publishing Group DOI: 10.1038/s41598-021-82498-5 SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses Auteurs: Marco Mandolesi, Daniel J. Sheward, Leo Hanke, Junjie Ma, Pradeepa Pushparaj, Laura Perez Vidakovics, Changil Kim, Monika Àdori, Klara Lenart, Karin Loré, Xaquin Castro Dopico, Jonathan M. Coquet, Gerald M. McInerney, Gunilla B. Karlsson Hedestam, Ben Murrell Publié dans: Cell Reports Medicine, Issue 2/4, 2021, Page(s) 100252, ISSN 2666-3791 Éditeur: Cell Press DOI: 10.1016/j.xcrm.2021.100252 Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study Auteurs: Sheward Dj, Kim C, Ehling Ra, Pankow A, Castro Dopico X, Dyrdak R, Martin Dp, Reddy St, Dillner J, Karlsson Hedestam Gb, Albert J, Murrell B Publié dans: The Lancet. Infectious diseases, 2022, ISSN 1473-3099 Éditeur: The Lancet Publishing Group DOI: 10.1016/s1473-3099(22)00129-3 A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo Auteurs: Leo Hanke, Hrishikesh Das, Daniel J. Sheward, Laura Perez Vidakovics, Egon Urgard, Ainhoa Moliner-Morro, Changil Kim, Vivien Karl, Alec Pankow, Natalie L. Smith, Bartlomiej Porebski, Oscar Fernandez-Capetillo, Erdinc Sezgin, Gabriel K. Pedersen, Jonathan M. Coquet, B. Martin Hällberg, Ben Murrell & Gerald M. McInerney Publié dans: Nature Communications, 2022, ISSN 2041-1723 Éditeur: Nature Publishing Group DOI: 10.1038/s41467-021-27610-z SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display Auteurs: Ehling, R.A., Weber, C.R., Mason, D.M., Friedensohn, S., Wagner, B., Bieberich, F., Kapetanovic, E., Vazquez-Lombardi, R., Di Roberto, R.B., Hong, K.-L., Wagner, C., Pataia, M., Overath, M.D., Sheward, D.J., Murrell, B., Yermanos, A., Cuny, A.P., Savic, M., Rudolf, F., Reddy, S.T. Publié dans: Cell Reports, 2022, ISSN 2211-1247 Éditeur: Cell Press DOI: 10.1016/j.celrep.2021.110242 Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions Auteurs: Manon Ragonnet-Cronin, Olivia Boyd, Lily Geidelberg, David Jorgensen, Fabricia F. Nascimento, Igor Siveroni, Robert A. Johnson, Marc Baguelin, Zulma M. Cucunubá, Elita Jauneikaite, Swapnil Mishra, Oliver J. Watson, Neil Ferguson, Anne Cori, Christl A. Donnelly, Erik Volz Publié dans: Nature Communications, Issue 12/1, 2021, ISSN 2041-1723 Éditeur: Nature Publishing Group DOI: 10.1038/s41467-021-22366-y A Multiparametric and High-Throughput Platform for Host–Virus Binding Screens Auteurs: Jan Schlegel; Bartlomiej Porebski; Luca Andronico; Leo Hanke; Steven Edwards; Hjalmar Brismar; Ben Murrell; Gerald M. McInerney; Oscar Fernandez-Capetillo; Erdinc Sezgin Publié dans: Nano Letters, Issue 1, 2023, ISSN 1530-6984 Éditeur: American Chemical Society DOI: 10.1021/acs.nanolett.2c04884 Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs Auteurs: Ainhoa Moliner-Morro, Daniel J. Sheward, Vivien Karl, Laura Perez Vidakovics, Ben Murrell, Gerald M. McInerney, Leo Hanke Publié dans: Biomolecules, Issue 10/12, 2020, Page(s) 1661, ISSN 2218-273X Éditeur: MDPI DOI: 10.3390/biom10121661 Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2 Auteurs: Tânia F. Custódio, Hrishikesh Das, Daniel J. Sheward, Leo Hanke, Samuel Pazicky, Joanna Pieprzyk, Michèle Sorgenfrei, Martin A. Schroer, Andrey Yu. Gruzinov, Cy M. Jeffries, Melissa A. Graewert, Dmitri I. Svergun, Nikolay Dobrev, Kim Remans, Markus A. Seeger, Gerald M. McInerney, Ben Murrell, B. Martin Hällberg, Christian Löw Publié dans: Nature Communications, Issue 11/1, 2020, ISSN 2041-1723 Éditeur: Nature Publishing Group DOI: 10.1038/s41467-020-19204-y Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape Auteurs: Paul-Albert Koenig, Hrishikesh Das, Hejun Liu, Beate M. Kümmerer, Florian N. Gohr, Lea-Marie Jenster, Lisa D. J. Schiffelers, Yonas M. Tesfamariam, Miki Uchima, Jennifer D. Wuerth, Karl Gatterdam, Natalia Ruetalo, Maria H. Christensen, Caroline I. Fandrey, Sabine Normann, Jan M. P. Tödtmann, Steffen Pritzl, Leo Hanke, Jannik Boos, Meng Yuan, Xueyong Zhu, Jonathan L. Schmid-Burgk, Hiroki Kato, Mi Publié dans: Science, Issue 371/6530, 2021, Page(s) eabe6230, ISSN 0036-8075 Éditeur: American Association for the Advancement of Science DOI: 10.1126/science.abe6230 Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden Auteurs: X. Castro Dopico, S. Muschiol, M. Christian, L. Hanke, D. J. Sheward, N. F. Grinberg, J. Rorbach, G. Bogdanovic, G. M. Mcinerney, T. Allander, C. Wallace, B. Murrell, J. Albert, G. B. Karlsson Hedestam Publié dans: Journal of Internal Medicine, 2021, ISSN 0954-6820 Éditeur: Blackwell Publishing Inc. DOI: 10.1111/joim.13304 An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction Auteurs: Leo Hanke, Laura Vidakovics Perez, Daniel J. Sheward, Hrishikesh Das, Tim Schulte, Ainhoa Moliner-Morro, Martin Corcoran, Adnane Achour, Gunilla B. Karlsson Hedestam, B. Martin Hällberg, Ben Murrell, Gerald M. McInerney Publié dans: Nature Communications, Issue 11/1, 2020, ISSN 2041-1723 Éditeur: Nature Publishing Group DOI: 10.1038/s41467-020-18174-5 Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level Auteurs: Anouschka Akerman Vanessa Milogiannakis Tyra Jean Camille Esneau Mariana Ruiz Silva Timothy Ison Christina Fichter Joseph A. Lopez Deborah Chandra Zin Naing Joanna Caguicla Daiyang Li Gregory Walker Supavadee Amatayakul-Chantler Nathan Roth Sandro Manni Thomas Hauser Thomas Barnes Anna Condylios Malinna Yeang Maureen Wong Charles S.P. Foster Kenta Sato Sharon Lee Yang Song Lijun Mao Allison Sigmun Publié dans: EBioMedicine, 2023, ISSN 2352-3964 Éditeur: Elsevier BV DOI: 10.1016/j.ebiom.2023.104545 Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice Auteurs: Katharina Wørzner, Daniel J. Sheward, Signe Tandrup Schmidt, Leo Hanke, Julie Zimmermann, Gerald McInerney, Gunilla B. Karlsson Hedestam, Ben Murrell, Dennis Christensen, Gabriel Kristian Pedersen Publié dans: EBioMedicine, Issue 63, 2021, Page(s) 103197, ISSN 2352-3964 Éditeur: Elsevier BV DOI: 10.1016/j.ebiom.2020.103197 Longitudinal single-cell analysis of SARS-CoV-2–reactive B cells uncovers persistence of early-formed, antigen-specific clones Auteurs: Lydia Scharf, Hannes Axelsson, Aikaterini Emmanouilidi, Nimitha R. Mathew, Daniel J. Sheward, Susannah Leach, Pauline Isakson, Ilya V. Smirnov, Emelie Marklund, Nicolae Miron, Lars-Magnus Andersson, Magnus Gisslén, Ben Murrell, Anna Lundgren, Mats Bemark, and Davide Angeletti Publié dans: JCI Insight, 2022, ISSN 2379-3708 Éditeur: American Society for Clinical Investigation (ASCI) DOI: 10.1172/jci.insight.165299 SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden Auteurs: Ann-Sofie Rudberg, Sebastian Havervall, Anna Månberg, August Jernbom Falk, Katherina Aguilera, Henry Ng, Lena Gabrielsson, Ann-Christin Salomonsson, Leo Hanke, Ben Murrell, Gerald McInerney, Jennie Olofsson, Eni Andersson, Cecilia Hellström, Shaghayegh Bayati, Sofia Bergström, Elisa Pin, Ronald Sjöberg, Hanna Tegel, My Hedhammar, Mia Phillipson, Peter Nilsson, Sophia Hober, Charlotte Thålin Publié dans: Nature Communications, Issue 11/1, 2020, ISSN 2041-1723 Éditeur: Nature Publishing Group DOI: 10.1038/s41467-020-18848-0 Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity Auteurs: Erik Volz, Verity Hill, John T. McCrone, Anna Price, David Jorgensen, Áine O’Toole, Joel Southgate, Robert Johnson, Ben Jackson, Fabricia F. Nascimento, Sara M. Rey, Samuel M. Nicholls, Rachel M. Colquhoun, Ana da Silva Filipe, James Shepherd, David J. Pascall, Rajiv Shah, Natasha Jesudason, Kathy Li, Ruth Jarrett, Nicole Pacchiarini, Matthew Bull, Lily Geidelberg, Igor Siveroni, Ian Goodfellow Publié dans: Cell, Issue 184/1, 2021, Page(s) 64-75.e11, ISSN 0092-8674 Éditeur: Cell Press DOI: 10.1016/j.cell.2020.11.020 Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2. Auteurs: Niclas Roxhed; Annika Bendes; Matilda Dale; Cecilia Mattsson; Leo Hanke; Tea Dodig-Crnković; Murray Christian; Birthe Meineke; Birthe Meineke; Simon J. Elsässer; Simon J. Elsässer; Juni Andréll; Sebastian Havervall; Charlotte Thålin; Carina Eklund; Joakim Dillner; Olof Beck; Cecilia Engel Thomas; Gerald M. McInerney; Mun-Gwan Hong; Ben Murrell; Claudia Fredolini; Jochen M. Schwenk Publié dans: Nature Communications, Issue 1, 2021, ISSN 2041-1723 Éditeur: Nature Publishing Group DOI: 10.1038/s41467-021-23893-4 Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies Auteurs: Hanke, L., Sheward, D.J., Pankow, A., Vidakovics, L.P., Karl, V., Kim, C., Urgard, E., Smith, N.L., Astorga-Wells, J., Ekström, S., Coquet, J.M., McInerney, G.M., Murrell, B Publié dans: Science Advances, 2022, ISSN 2375-2548 Éditeur: American Association for the Advancement of Science DOI: 10.1126/sciadv.abm0220 Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates Auteurs: Xaquin Castro Dopico; Sandra Muschiol; Nastasiya F Grinberg; Soo Aleman; Daniel J Sheward; Leo Hanke; Marcus Ahl; Linnea Vikström; Mattias Forsell; Jonathan M Coquet; Gerald McInerney; Joakim Dillner; Gordana Bogdanovic; Ben Murrell; Jan Albert; Chris Wallace; Gunilla B Karlsson Hedestam Publié dans: Clinical & Translational Immunology, Issue 1, 2022, ISSN 2050-0068 Éditeur: Wiley DOI: 10.1002/cti2.1379 Nanobodies in the limelight: Multifunctional tools in the fight against viruses Auteurs: Ainhoa Moliner-Morro, Gerald M McInerney, Leo Hanke Publié dans: Journal of General Virology, 2022, ISSN 1743-422X Éditeur: BioMed Central DOI: 10.1099/jgv.0.001731 Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models Auteurs: Sheward Dj, Mandolesi M, Urgard E, Kim C, Hanke L, Perez Vidakovics L, Pankow A, Smith Nl, Castro Dopico X, Mcinerney Gm, Coquet Jm, Karlsson Hedestam Gb, Murrell B Publié dans: Cell Reports Medicine, 2021, ISSN 2666-3791 Éditeur: Cell Press DOI: 10.1016/j.xcrm.2021.100450 Recherche de données OpenAIRE... Une erreur s’est produite lors de la recherche de données OpenAIRE Aucun résultat disponible
